KRAS and cholangiocarcinoma: Moreover, using an independent cohort of metastatic cholangiocarcinoma and mPDAC from the Hartwig study, we validated our findings of the transcriptional similarity between cholangiocarcinoma and, specifically, KRAS wildtype mPDAC tumors.